Jiangsu Wengao Pharmaceutical

Jiangsu Wengao Pharmaceutical is a specialized manufacturer of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs) based in Changzhou, China. The company focuses on the development and production of high-purity chemical compounds used in the synthesis of drugs for oncology, cardiovascular diseases, and metabolic disorders. With a strong emphasis on R&D and quality control, Wengao Pharmaceutical serves as a key supplier to the global pharmaceutical industry, providing essential building blocks for both generic and innovative medications. Their facilities are equipped for complex chemical synthesis and large-scale production, ensuring compliance with international regulatory standards. The company's product portfolio includes intermediates for major drugs such as Imatinib, Nilotinib, and Sitagliptin.